Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Short-Term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This study has been completed.
Study NCT01336972 Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.
First Received on April 15, 2011. Last Updated on December 5, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Polycystic Kidney Diseases
Polycystic Kidney, Autosomal Dominant
More general conditions related to this trial
Kidney Diseases, Cystic
Interventions listed in this trial
Sponsors listed in this trial
Otsuka Pharmaceutical Development & Commercialization, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers